arrow
T

Terri Lynn Shigle

The University of Texas MD Anderson Cancer Center
H指数:11
被引数:713

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The interplay between Epstein-Barr Virus and Cytomegalovirus reactivation following allogeneic hematopoietic cell transplantation in the era of primary CMV prophylaxis

同种异基因造血细胞移植后,在主要巨细胞病毒(CMV)预防时代,爱泼斯坦-巴尔病毒(Epstein-Barr Virus)与巨细胞病毒(Cytomegalovirus)再激活的相互作用

2025-08-250
PRE
American Society of Transplantation and Cellular Therapy Series: #8-Management and Prevention of Non-Aspergillus Molds in Hematopoietic Cell Transplantation Recipients

美国移植与细胞治疗学会系列: #8-造血细胞移植受者中非曲霉菌的管理和预防

2025-02-010
PRE
Mortality in recipients of allogeneic haematopoietic cell transplantation in the era of cytomegalovirus primary prophylaxis: a single-centre retrospective experience
2024-06-011
PRE
High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma

大剂量化疗联合自体干细胞移植治疗复发或难治性原发性纵隔大b细胞淋巴瘤

2023-11-014
PRE
Myeloablative fractionated busulfan for allogeneic stem cell transplant in older patients or patients with comorbidities
2023-10-132
OAAI
Feasibility and Implementation of a Multimodal Supportive Care Program to Improve Outcomes in Older Patients Undergoing Allogeneic Stem Cell Transplantation

改善接受异基因干细胞移植的老年患者预后的多模式支持性护理计划的可行性和实施

2021-12-016
OAAI
Improved outcomes of high-risk relapsed Hodgkin lymphoma patients after high-dose chemotherapy: a 15-year analysis
2021-05-0612
OAAI
Vedolizumab for Steroid Refractory Lower Gastrointestinal Tract Graft-Versus-Host Disease

维多珠单抗治疗类固醇难治性下消化道移植物抗宿主病

2021-03-0114
OAAI